Skip to main content
Frontiers in Immunology logoLink to Frontiers in Immunology
. 2016 Sep 14;7:354. doi: 10.3389/fimmu.2016.00354

Corrigendum: Recent Advances in Lentiviral Vaccines for HIV-1 Infection

Thomas D Norton 1, Elizabeth A Miller 2,*
PMCID: PMC5021684  PMID: 27630642

In the original article, an error in the references in the section entitled “Addressing Safety Concerns with LV Vaccine Vectors” is present. Reference number 20 which is cited twice in this section is an error and should instead be Di Nunzio et al. (1).

The authors apologize for this. This error does not change the scientific conclusions of the article in any way.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Reference

  • 1.Di Nunzio F, Félix T, Arhel NJ, Nisole S, Charneau P, Beignon AS. HIV-derived vectors for therapy and vaccination against HIV. Vaccine (2012) 30:2499–509. 10.1016/j.vaccine.2012.01.089 [DOI] [PubMed] [Google Scholar]

Articles from Frontiers in Immunology are provided here courtesy of Frontiers Media SA

RESOURCES